Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

EPA Awards $27 Million Contract to Expression Analaysis

Published: Thursday, August 09, 2012
Last Updated: Thursday, August 09, 2012
Bookmark and Share
Renewed contract for expansion of ToxCast's genomic data.

The Environmental Protection Agency's (EPA) ToxCast™ Program, launched to forecast the toxicity of chemical compounds for humans and the environment, is expanding genomic data collection through a renewed five-year contract with Expression Analysis (EA), which will serve as the program's primary contractor for RNA biomarker analysis.

The $27 million contract calls for EA to investigate toxicology-related RNA biomarkers for up to 12,100 compounds in 121,100 biological samples using high-throughput PCR assays, gene expression microarrays, and transcriptome sequencing. EA will perform bioinformatic and statistical analyses to ensure the end-point data incorporated into the ToxCast database accurately represent the biology of the sample and are not subject to assay artifacts or batch-related effects.

"Our role is to provide reproducible end-point data for the EPA's toxicologists who are the primary investigators for ToxCast. The integrity of genomic data for this long-term study is crucial. ToxCast has the potential to greatly enhance the EPA's ability to predict the toxicity of various chemicals as well as prioritize the chemicals for rigorous toxicity testing," says Wendell Jones, Ph.D., Vice President of Bioinformatics and Statistics at EA.

All work will be conducted in EA's GLP-compliant, CLIA-certified laboratories under rigorous quality control standards. As structured in the previous contract, the EPA will review detailed Standard Operating Protocols for every assay performed and audit EA's facilities at the discretion of the Director of Quality Assurance at the National Center for Computational Toxicology.

Existing ToxCast initiatives have profiled approximately 2,000 chemicals from a broad range of sources, including industrial and consumer products, pesticides, food additives, products advertised as "green," nanomaterials and drugs not placed on the market.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Expression Analysis Announces 2013 Grant Program
Two recipients to receive cutting-edge services from Expression Analysis and Illumina to advance new applications in genomics research.
Monday, April 08, 2013
Expression Analysis Welcomes New Vice President of Operations
EA announces the addition of Tyler Aldredge to its executive management team. Tyler will assume the role of Vice President of Laboratory Operations.
Wednesday, September 21, 2011
Expression Analysis Hires Director of Business Development
Expression Analysis announces that Jeff Fitzgerald has joined their management team as Director of Business Development.
Friday, September 09, 2011
Expression Analysis Adopts Cure Kids Cancer Coalition
Fund-raising will begin at Upcoming American Society of Human Genetics Meeting.
Monday, November 03, 2008
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Study Identifies the Off Switch for Biofilm Formation
New discovery could help prevent the formation of infectious bacterial films on hospital equipment.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Combo Tool
Joining molecular components expands ability to manipulate genes in specific cell types.
Team Identifies Structure of Tumor-Suppressing Protein
An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN.
Genes Associated With Improved Survival for Pancreatic Cancer Patients
Use of non-invasive liquid biopsies could predict in which patients the cancer could recur following surgery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!